Previous close | 132.36 |
Open | 134.91 |
Bid | 140.77 x 100 |
Ask | 140.98 x 100 |
Day's range | 134.35 - 143.77 |
52-week range | 110.45 - 211.13 |
Volume | |
Avg. volume | 711,852 |
Market cap | 7.867B |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | 541.50 |
EPS (TTM) | 0.26 |
Earnings date | 30 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 191.34 |
Exact Sciences (EXAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
We recently compiled a list of the 20 Most Profitable Stocks of the Last 20 Years. In this article, we are going to take a look at where Repligen Corporation (NASDAQ:RGEN) stands against the other profitable stocks. The stock market has a long history of generating wealth for investors. While past performance doesn’t guarantee future […]